Kirkland & Ellis and Arnold & Porter Kaye Scholer LLP have advised Curium. Covington & Burling LLP and Ropes & Gray LLP have advised Lantheus. Curium...
Curium to Acquire Lantheus in $8 Billion Merger
UCB to Acquire Candid Therapeutics in $2.2 Billion Deal
Cooley and Wilson Sonsini Goodrich & Rosati have advised Candid Therapeutics. Covington & Burling has represented UCB. UCB, a global biopharmaceutical company, has announced a definitive...
Athyrium and Esperion in $50 Million Japan Royalty Financing to Support Corstasis Acquisition
Covington & Burling LLP and Paul Hastings LLP have advised Athyrium Capital Management. Gibson, Dunn & Crutcher LLP has served as legal advisor to Esperion Therapeutics,...
Eaton Acquires Ultra PCS Limited for $1.55 Billion
Covington & Burling has advised Eaton on the transaction, while Weil has advised the Cobham Ultra Group. Eaton has entered into a definitive agreement to acquire...
BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction
Skadden and NautaDutilh N.V. have advised CureVac. Covington & Burling LLP, Hengeler Mueller Partnerschaft von Rechtsanwälten mbB and Loyens & Loeff N.V. have advised BioNTech. BioNTech...
OrbiMed Advisors’ $208 Million Acquisition of Neurelis
Covington & Burling advised an affiliate of OrbiMed Advisors on the transaction. OrbiMed Advisors announced its agreement to purchase 100% of Neurelis Inc.’s rights, royalty interests,...
Insmed’s $150 Million Credit Facility Upsize with Pharmakon
Covington & Burling advised Insmed Incorporated on the transaction. Insmed Incorporated (Nasdaq: INSM) (“Insmed”) announced its entrance into an agreement to amend its $350 million term...
Getinge’s $477 Million Acquisition of Paragonix Technologies
Covington & Burling represented Getinge in the transaction. Getinge announced its acquisition of Paragonix Technologies, Inc., a leading organ transport products and services company in the...
Selecta Biosciences’ Merger with Cartesian Therapeutics
Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics. Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent...
DRI Healthcare Trust’s $85 Million of Royalty Interest in Breast Cancer Treatment
Covington advised Eisai in the transaction. Eisai Co., Ltd. signed its agreement to transfer all future economic rights for elacestrant (generic name), approved for the treatment for...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...